Cardiology
Cardiac rehabilitation improves heart rate recovery, boosts survival
For the first time, researchers have discovered cardiac rehabilitation can train the heart to quickly return to its normal rate after exercise.
Sep 26, 2011
0
0
News tagged with blockbuster drug
Medications
Novartis fights patent rejection in Indian court
(AP) -- In a case that could affect India's role as drug provider to the developing world, the Supreme Court began hearing arguments Tuesday over whether the government had the right to deny a patent to Swiss drugmaker Novartis ...
Sep 6, 2011
0
0
Other
Change at the top for Biogen after Alzheimer's drug flops
Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer's drug Aduhelm less than a year after the medication's launch triggered a backlash from experts, doctors and insurers.
May 3, 2022
0
10
Other
AbbVie raises outlook as Humira again delivers earnings beat
Drugmaker AbbVie is raising its full-year earnings guidance after reporting better-than-expected first quarter adjusted results on continued growth of its blockbuster anti-inflammatory drug Humira.
Apr 23, 2015
0
4
Medications
Lundbeck profit jumps but warns on generic pressure
Danish pharmaceutical company Lundbeck Wednesday posted a higher than expected quarterly net profit, helped by the expansion of an alliance with Japan's Otsuka and the divestment of a US portfolio of non-core products.
May 1, 2013
0
0
Medications
FDA reviewing heart risks of Glaxo diabetes pill
(AP)—The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline's former blockbuster diabetes drug Avandia.
Apr 12, 2013
0
0
Other
Pfizer Q4 net jumps on sale of nutrition business
Pfizer Inc.'s fourth-quarter profit more than quadrupled, despite competition from generic drugs hurting sales of Lipitor and other medicines, because of a $4.8 billion gain from selling its nutrition business. The drugmaker's ...
Jan 29, 2013
0
0
Medications
FDA clears anticlotting drug Eliquis
The Food and Drug Administration says it has approved the anticlotting drug Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc. It's a potential blockbuster drug in a new category of medicines to prevent strokes ...
Dec 28, 2012
0
0
Medications
FDA backs Vytorin for kidney disease patients
(AP) -- The Food and Drug Administration says Merck's cholesterol drug Vytorin helps reduce heart attack, stroke and related problems in patients with kidney disease, a potential new use for the blockbuster drug.
Oct 31, 2011
0
0
